CASI Pharmaceuticals, Inc. (CASIF) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $62.93M | +21.4% |
| 2024 | $51.82M | +1.4% |
| 2023 | $51.10M | +74.4% |
| 2022 | $29.30M | -3.4% |
| 2021 | $30.34M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $62.93M | +21.4% |
| 2024 | $51.82M | +1.4% |
| 2023 | $51.10M | +74.4% |
| 2022 | $29.30M | -3.4% |
| 2021 | $30.34M | — |